Dr. McMurry-Heath is an accomplished physician-scientist and the Founder and CEO of BioTechquity Clinical, a pioneering clinical research organization dedicated to promoting diversity in clinical trials for drug and device developers.
With an extensive background in regulatory and clinical leadership, she previously served as the CEO of the Biotechnology Innovation Organization (BIO), where she led the transformative BIOEquality Agenda. Dr. McMurry-Heath's experience includes significant roles at the US Food & Drug Administration (FDA) and Johnson & Johnson, where she managed a global team responsible for trials and regulatory approvals across over 150 countries.
Her career highlights include:
Policymaker Experience: A solid foundation as a policymaker, having worked on Capitol Hill and amassed in-depth knowledge of agency policy development and future directions during her tenure at the FDA and the Senate.
Regulatory Leadership: Proven success as a regulatory leader in the biotech industry, where she has negotiated with global regulators, including those in China, Germany, the UK, Japan, Brazil, Russia, and the Middle East, facilitating approvals in more than 150 markets.
Clinical Trial Expertise: A former clinical trial leader, Dr. McMurry-Heath has a robust record of designing and conducting complex Premarket Approval (PMA) and Biologics License Application (BLA) trials to secure regulatory approval.
Policy Advocacy: Skilled in representing and shaping policies to advance the biotech and life sciences sector in the US while engaging with governments worldwide.
Dr. McMurry-Heath champions the belief that inclusive and equitable medical innovation has the potential to transform lives and create opportunities for all. As the Founding Director of the Aspen Institute Health Program, she is committed to fostering advancements in healthcare and improving access for diverse populations.